Roy Taylor

Professor Roy Taylor is a leading academic at Newcastle University's School of Medicine, specializing in Endocrinology and Diabetes. His research focuses on reversing Type 2 diabetes through metabolic interventions, weight loss mechanisms, and clinical implementation of remission programs.

• Lead investigator of the Diabetes Remission Clinical Trial (DiRECT)
• Developer of the Twin Cycle Hypothesis for diabetes pathogenesis
• Expert in gestational diabetes and maternal-fetal metabolic health

Research Themes: Taylor's work spans diabetes remission, intraorgan fat dynamics, bariatric surgery alternatives, and cardiometabolic health improvements via weight loss. His studies integrate metabolomics, proteomics, and MRI imaging to understand liver and pancreatic fat metabolism.

Article Trends: Recent publications emphasize real-world diabetes remission programs (NHS Path to Remission), gestational diabetes interventions (DiGest trial), and multi-omic biomarker discovery (metabolomics, proteomics). Collaborations with international diabetes organizations and UK biobank studies are prominent.

Scientific Awards:

• Banting Memorial Lecture (2012)

Program Leadership: Taylor oversees major clinical trials including DiRECT, ReTUNE (non-obese diabetes reversal), and DiGest (gestational diabetes management). His work influences national diabetes policies and primary care implementation strategies.